Global Information
회사소개 | 문의 | 비교리스트

약물 남용 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측

Substance Abuse Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

리서치사 Transparency Market Research
발행일 2019년 03월 상품 코드 823552
페이지 정보 영문 217 Pages
가격
US $ 5,795 ₩ 7,237,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 10,984,000 PDF by E-mail (5-user License) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 14,730,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


약물 남용 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측 Substance Abuse Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
발행일 : 2019년 03월 페이지 정보 : 영문 217 Pages

세계의 약물 남용 치료(Substance Abuse Treatment) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장에 참여하는 기업 개요에 대해 정리했습니다.

제1장 서론

제2장 가정과 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 서론
  • 업계 동향
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 기회
    • 동향
  • 시장 예측
  • Porter's Five Forces
  • 파이프라인 분석
  • 인수합병
  • 규제 시나리오

제5장 치료별 시장 분석과 예측

  • 서론과 정의
  • 조사 결과
  • 시장 분석
  • 시장 예측
    • 알코올 중독
    • 니코틴 중독
    • 약물 남용
  • 시장 매력도 분석

제6장 유통 채널별 시장 분석과 예측

  • 서론과 정의
  • 조사 결과
  • 시장 분석
  • 시장 가치 예측
    • 원내 약국
    • 소매 약국 및 드럭스토어
    • 기타
  • 시장 매력도 분석

제7장 지역별 시장 분석과 예측

  • 서론과 정의
  • 조사 결과
  • 시장 가치 예측
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력도 분석

제8장 북미 시장

제9장 유럽 시장

제10장 아시아태평양 시장

제11장 라틴아메리카 시장

제12장 중동 및 아프리카 시장

제13장 경쟁 상황

  • 경쟁 매트릭스
  • 기업 점유율
  • 시장 분석
  • 기업 개요
  • 경쟁 비지니스 전략
KSM 19.04.25

List of Tables

  • Table 1: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 2: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
  • Table 3: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment,
  • Table 4: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016-2026
  • Table 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 6: Global Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 7: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 8: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016-2026
  • Table 9: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016-2026
  • Table 10: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016-2026
  • Table 11: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
  • Table 12: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 13: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 14: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
  • Table 15: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016-2026
  • Table 16: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016-2026
  • Table 17: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 18: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 19: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 20: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016-2026
  • Table 21: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016-2026
  • Table 22: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment,
  • Table 23: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
  • Table 24: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 25: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 26: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016-2026
  • Table 27: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016-2026
  • Table 28: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016-2026
  • Table 29: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 30: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
  • Table 31: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016-2026
  • Table 32: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016-2026
  • Table 33: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016-2026
  • Table 34: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016-2026
  • Table 35: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016-2026
  • Table 36: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • Figure 1: Global Substance Abuse Treatment Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2: Global Substance Abuse Treatment Market Value (US$ Mn), by Treatment Type, 2017
  • Figure 3: Global Substance Abuse Treatment Market Value (US$ Mn), by Distribution Channel, 2017
  • Figure 4: Global Substance Abuse Treatment Market Opportunity Map, by Treatment Type
  • Figure 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 6: Global Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2026
  • Figure 7: Global Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 8: Alcohol Addiction Treatment Segment, 2016-2026
  • Figure 9: Nicotine Addiction Treatment Segment, 2016-2026
  • Figure 10: Drug Abuse Treatment Segment, 2016-2026
  • Figure 11: Global Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 12: Global Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018-2026
  • Figure 13: By Acamprosate Sub-segment, 2016-2026
  • Figure 14: By Disulphirum Sub-segment, 2016-2026
  • Figure 15: By Naltrexone Sub-segment, 2016-2026
  • Figure 16: By Benzodiazepine (BZD) Sub-segment, 2016-2026
  • Figure 17: Global Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 18: Global Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018-2026
  • Figure 19: by Total NRT Therapy Segment, 2016-2026
  • Figure 20: by Varenicline Segment, 2016-2026
  • Figure 21: by Bupropion Segment, 2016-2026
  • Figure 22: Global Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 23: Global Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 24: By Methadone Segment, 2016-2026
  • Figure 25: by Buprenorphine Segment, 2016-2026
  • Figure 26: by Naltexone Segment, 2016-2026
  • Figure 27: Global Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 28: Global Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 29: By Hospital Pharmacies Segment, 2016-2026
  • Figure 30: by Retail Pharmacies and Drug Stores Segment, 2016-2026
  • Figure 31: by Others (Online Sales) Segment, 2016-2026
  • Figure 32: Global Substance Abuse Treatment Market Attractiveness, by Region, 2018 and 2026
  • Figure 33: North America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
  • Figure 34: North America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
  • Figure 35: North America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 36: North America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 37: North America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
  • Figure 38: North America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 39: North America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018-2026
  • Figure 40: North America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 41: North America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 42: North America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 43: North America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 44: North America Substance Abuse Treatment Market Value Share, by Country, 2017 and 2026
  • Figure 45: North America Substance Abuse Treatment Market Attractiveness, by Country, 2018-2026
  • Figure 46: Europe Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
  • Figure 47: Europe Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
  • Figure 48: Europe Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 49: Europe Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 50: Europe Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
  • Figure 51: Europe Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 52: Europe Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018-2026
  • Figure 53: Europe Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 54: Europe Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 55: Europe Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 56: Europe Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 57: Europe Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 58: Europe Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 59: Asia Pacific Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
  • Figure 60: Asia Pacific Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
  • Figure 61: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 62: Asia Pacific Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 63: Asia Pacific Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
  • Figure 64: Asia Pacific Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 65: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018-2026
  • Figure 66: Asia Pacific Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 67: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 68: Asia Pacific Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 69: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 70: Asia Pacific Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 71: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 72: Latin America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Treatment Type, 2016 and 2026
  • Figure 73: Latin America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
  • Figure 74: Latin America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 75: Latin America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 76: Latin America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
  • Figure 77: Latin America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 78: Latin America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018-2026
  • Figure 79: Latin America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 80: Latin America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 81: Latin America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 82: Latin America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 83: Latin America Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 84: Latin America Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 85: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 86: Middle East & Africa Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
  • Figure 87: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
  • Figure 88: Middle East & Africa Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
  • Figure 89: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018-2026
  • Figure 90: Middle East & Africa Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
  • Figure 91: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment,
  • Figure 92: Middle East & Africa Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
  • Figure 93: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018-2026
  • Figure 94: Middle East & Africa Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 95: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018-2026
  • Figure 96: Middle East & Africa Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 97: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018-2026

Title:
Substance Abuse Treatment Market (Treatment Type - Drug Abuse Treatment (Methadone, Buprenorphine, Naltexone), Nicotine Addiction Treatment (Total NRT Therapy, Varenicline, Bupropion), Alcohol Addiction Treatment (Acamprosate, Disulphirum, Naltrexone, Benzodiazepines); Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, Others (Online Sales)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Substance Abuse Treatment Market: Overview

Substance abuse is use of psychoactive substances, including alcohol and illicit drugs. Use of psychoactive substances can lead to dependence syndrome (a combination of behavioral, cognitive, and psychological phenomenon, which forces the individual to use alcohol, nicotine, and illicit drugs). Awareness about initiatives by manufacturers and governments and rise in abuse of prescription drugs are likely to fuel the global substance abuse treatment market from 2018 to 2026.

The global substance abuse treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment type, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global substance abuse treatment market.

Global Substance Abuse Treatment Market: Key Segments

The report offers detailed segmentation of the global substance abuse treatment market. Based on treatment type, the global substance abuse treatment market has been classified into alcohol addiction treatment, nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is likely to expand at a prominent growth rate during the forecast period, due to increasing consumption of alcohol worldwide, rising use of medicines for restriction of alcohol consumption, and relatively lower cost per prescription for these medicines. The duration of action is also an important driver of the segment.

On the other hand, expansion of the drug abuse treatment segment is attributed to a rise in the usage of prescription drugs/illicit drugs, increase in the number of deaths from excessive use of prescription drugs, and a surge in research & development by leading pharmaceutical companies.

In terms of distribution channel, the global substance abuse treatment market has been categorized into hospital pharmacies, retail pharmacies and drug stores, and others (online sales). Expansion of the segment can be attributed to the rise in prescription filling at hospital pharmacies, availability of certified physicians in hospital pharmacies, advice for use of the drugs from certified physicians, and authenticity of quality and price of medicines. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Substance Abuse Treatment Market: Regional Outlook

In terms of region, the global substance abuse treatment market has been segmented into five major regions and the key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries and Rest of Middle East & Africa ). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the global substance abuse treatment market are Alkermes, Allergan PLC, Indivior PLC, Noramco (part of SK Capital Partners), and Teva Pharmaceutical Industries Ltd. Other players include Pfizer, Inc., GlaxoSmithKline plc, Mallinckrodt plc, BioCorRx, Inc., and Glenmark Pharmaceuticals Ltd.

The global substance abuse treatment market has been segmented as follows:

Global Substance Abuse Treatment Market, by Treatment Type

  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltexone
  • Nicotine Addiction Treatment
    • Total NRT therapy
    • Varenicline
    • Bupropion
  • Alcohol Addiction Treatment
    • Acamprosate
    • Disulphirum
    • Naltrexone
    • Benzodiazepines (BZD)

Global Substance Abuse Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies and Drug Stores
  • Others (Online Sales)

Global Substance Abuse Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights
  • 1.3. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key Industry Evolution/Developments
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Awareness about Initiatives by Manufacturers and Governments
      • 4.3.1.2. Favorable Reimbursements for Smoking Cessation Therapy and Growth in the Number of Private Insurance Players
      • 4.3.1.3. Surge in Disposable Income
      • 4.3.1.4. Growing Abuse of Prescription Drugs
    • 4.3.2. Restraints
      • 4.3.2.1. Low Awareness about Addiction Treatment Products in Developing Countries
      • 4.3.2.2. Legal Obligations for Addiction Treatment Products
    • 4.3.3. Opportunities
      • 4.3.3.1. Research and Development
      • 4.3.3.2. Introduction of New Products
    • 4.3.4. Trends
      • 4.3.4.1. Rise in Mergers and Acquisitions in the Industry
      • 4.3.4.2. Government Initiatives and Funding
  • 4.4. Global Substance Abuse Treatment Market Forecast
  • 4.5. Porter's Five Forces
  • 4.6. Pipeline Analysis
  • 4.7. Porter's Five Forces
  • 4.8. Key Mergers and Acquisitions
  • 4.9. Regulatory Scenario

5. Global Substance Abuse Treatment Market, by Treatment Type

  • 5.1. Introduction and Definitions
  • 5.2. Key Findings
  • 5.3. Global Substance Abuse Treatment Market Analysis, by Treatment Type
  • 5.4. Global Substance Abuse Treatment Market Forecast, by Treatment Type
    • 5.4.1. Alcohol Addiction Treatment
      • 5.4.1.1. Acamprosate;
      • 5.4.1.2. Disulphirum;
      • 5.4.1.3. Naltrexone;
      • 5.4.1.4. Benzodiazepines Wound Care Devices
    • 5.4.2. Nicotine Addiction Treatment
      • 5.4.2.1. Total NRT therapy ;
      • 5.4.2.2. Varenicline;
      • 5.4.2.3. Bupropion
    • 5.4.3. Drug Abuse Treatment
      • 5.4.3.1. Methadone;
      • 5.4.3.2. Buprenorphine;
      • 5.4.3.3. Naltexone
  • 5.5. Global Substance Abuse Treatment Market Attractiveness Analysis, by Treatment Type

6. Global Substance Abuse Treatment Market Analysis and Forecast, by Distribution Channel

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Substance Abuse Treatment Market Value Forecast, by Distribution Channel, 2016-2026
    • 6.3.1. Hospital Pharmacies;
    • 6.3.2. Retail Pharmacies and Drug Stores;
    • 6.3.3. Others (Online Sales)
  • 6.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel

7. Global Substance Abuse Treatment Market Analysis and Forecast, by Region

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Substance Abuse Treatment Market Value Forecast, by End-user, 2016-2026
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia-Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Region

8. North America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026

  • 8.1. Key Findings
  • 8.2. North America Substance Abuse Treatment Market Overview
  • 8.3. North America Substance Abuse Treatment Market Value Share Analysis, by Country
  • 8.4. North America Substance Abuse Treatment Market Size and Forecast, by Country
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. North America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
  • 8.6. North America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
    • 8.6.1. Alcohol Addiction Treatment
      • 8.6.1.1. Acamprosate;
      • 8.6.1.2. Disulphirum;
      • 8.6.1.3. Naltrexone;
      • 8.6.1.4. Benzodiazepines
    • 8.6.2. Nicotine Addiction Treatment
      • 8.6.2.1. Total NRT therapy ;
      • 8.6.2.2. Varenicline;
      • 8.6.2.3. Bupropion
    • 8.6.3. Drug Abuse Treatment
      • 8.6.3.1. Methadone;
      • 8.6.3.2. Buprenorphine;
      • 8.6.3.3. Naltexone
  • 8.7. North America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel
  • 8.8. North America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
    • 8.8.1. Hospital Pharmacies;
    • 8.8.2. Retail Pharmacies and Drug Stores;
    • 8.8.3. Others (Online Sales)
  • 8.9. North America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
    • 8.9.1. By Treatment Type
    • 8.9.2. By Distribution Channel
    • 8.9.3. By Country

9. Europe Substance Abuse Treatment Market Analysis and Forecast, 2018-2026

  • 9.1. Key Findings
  • 9.2. Europe Substance Abuse Treatment Market Overview
  • 9.3. Europe Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
  • 9.4. Europe Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. U.K.
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Europe Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
  • 9.6. Europe Substance Abuse Treatment Market Size and Forecast, by Treatment Type
    • 9.6.1. Alcohol Addiction Treatment
      • 9.6.1.1. Acamprosate;
      • 9.6.1.2. Disulphirum;
      • 9.6.1.3. Naltrexone;
      • 9.6.1.4. Benzodiazepines
    • 9.6.2. Nicotine Addiction Treatment
      • 9.6.2.1. Total NRT therapy ;
      • 9.6.2.2. Varenicline;
      • 9.6.2.3. Bupropion
    • 9.6.3. Drug Abuse Treatment
      • 9.6.3.1. Methadone;
      • 9.6.3.2. Buprenorphine;
      • 9.6.3.3. Naltexone
  • 9.7. Europe Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel
  • 9.8. Europe Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
    • 9.8.1. Hospital Pharmacies;
    • 9.8.2. Retail Pharmacies and Drug Stores;
    • 9.8.3. Others (Online Sales)
  • 9.9. Europe Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
    • 9.9.1. By Treatment Type
    • 9.9.2. By Distribution Channel
    • 9.9.3. By Country/Sub-region

10. Asia Pacific Substance Abuse Treatment Market Analysis and Forecast, 2018-2026

  • 10.1. Key Findings
  • 10.2. Asia Pacific Substance Abuse Treatment Market Overview
  • 10.3. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
  • 10.4. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
  • 10.6. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Treatment Type
    • 10.6.1. Alcohol Addiction Treatment
      • 10.6.1.1. Acamprosate;
      • 10.6.1.2. Disulphirum;
      • 10.6.1.3. Naltrexone;
      • 10.6.1.4. Benzodiazepines
    • 10.6.2. Nicotine Addiction Treatment
      • 10.6.2.1. Total NRT therapy ;
      • 10.6.2.2. Varenicline;
      • 10.6.2.3. Bupropion
    • 10.6.3. Drug Abuse Treatment
      • 10.6.3.1. Methadone;
      • 10.6.3.2. Buprenorphine;
      • 10.6.3.3. Naltexone
  • 10.7. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel
  • 10.8. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
    • 10.8.1. Hospital Pharmacies;
    • 10.8.2. Retail Pharmacies and Drug Stores;
    • 10.8.3. Others (Online Sales)
  • 10.9. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
    • 10.9.1. By Treatment Type
    • 10.9.2. By Distribution Channel
    • 10.9.3. By Country/Sub-region

11. Latin America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026

  • 11.1. Key Findings
  • 11.2. Latin America Substance Abuse Treatment Market Overview
  • 11.3. Latin America Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
  • 11.4. Latin America Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Latin America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
  • 11.6. Latin America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
    • 11.6.1. Alcohol Addiction Treatment
      • 11.6.1.1. Acamprosate;
      • 11.6.1.2. Disulphirum;
      • 11.6.1.3. Naltrexone;
      • 11.6.1.4. Benzodiazepines
    • 11.6.2. Nicotine Addiction Treatment
      • 11.6.2.1. Total NRT therapy ;
      • 11.6.2.2. Varenicline;
      • 11.6.2.3. Bupropion
    • 11.6.3. Drug Abuse Treatment
      • 11.6.3.1. Methadone;
      • 11.6.3.2. Buprenorphine;
      • 11.6.3.3. Naltexone
  • 11.7. Latin America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel
  • 11.8. Latin America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
    • 11.8.1. Hospital Pharmacies;
    • 11.8.2. Retail Pharmacies and Drug Stores;
    • 11.8.3. Others (Online Sales)
  • 11.9. Latin America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
    • 11.9.1. By Treatment Type
    • 11.9.2. By Distribution Channel
    • 11.9.3. By Country/Sub-region

12. Middle East & Africa Substance Abuse Treatment Market Analysis and Forecast, 2018-2026

  • 12.1. Key Findings
  • 12.2. Middle East & Africa Substance Abuse Treatment Market Overview
  • 12.3. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
  • 12.4. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
    • 12.4.1. South Africa
    • 12.4.2. GCC
    • 12.4.3. Israel
    • 12.4.4. Rest of Middle East & Africa
  • 12.5. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
  • 12.6. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Treatment Type
    • 12.6.1. Alcohol Addiction Treatment
      • 12.6.1.1. Acamprosate;
      • 12.6.1.2. Disulphirum;
      • 12.6.1.3. Naltrexone;
      • 12.6.1.4. Benzodiazepines
    • 12.6.2. Nicotine Addiction Treatment
      • 12.6.2.1. Total NRT therapy ;
      • 12.6.2.2. Varenicline;
      • 12.6.2.3. Bupropion
    • 12.6.3. Drug Abuse Treatment
      • 12.6.3.1. Methadone;
      • 12.6.3.2. Buprenorphine;
      • 12.6.3.3. Naltexone
  • 12.7. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel
  • 12.8. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
    • 12.8.1. Hospital Pharmacies;
    • 12.8.2. Retail Pharmacies and Drug Stores;
    • 12.8.3. Others (Online Sales)
  • 12.9. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
    • 12.9.1. By Treatment Type
    • 12.9.2. By Distribution Channel
    • 12.9.3. By Country/Sub-region

13. Competitive Landscape

  • 13.1. Competition Metrix
  • 13.2. Company Share
  • 13.3. Market Footprint Analysis
  • 13.4. Company Profiles
    • 13.4.1. Alkermes
      • 13.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.1.2. Financial Overview
      • 13.4.1.3. Product Portfolio
      • 13.4.1.4. SWOT Analysis
      • 13.4.1.5. Strategic Overview
    • 13.4.2. Allergan PLC,
      • 13.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.2.2. Financial Overview
      • 13.4.2.3. Product Portfolio
      • 13.4.2.4. SWOT Analysis
      • 13.4.2.5. Strategic Overview
    • 13.4.3. Indivior PLC,
      • 13.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.3.2. Financial Overview
      • 13.4.3.3. Product Portfolio
      • 13.4.3.4. SWOT Analysis
      • 13.4.3.5. Strategic Overview
    • 13.4.4. Noramco (part of SK Capital Partners),
      • 13.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.4.2. Financial Overview
      • 13.4.4.3. Product Portfolio
      • 13.4.4.4. SWOT Analysis
      • 13.4.4.5. Strategic Overview
    • 13.4.5. Teva Pharmaceutical Industries Ltd,
      • 13.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.5.2. Financial Overview
      • 13.4.5.3. Product Portfolio
      • 13.4.5.4. SWOT Analysis
      • 13.4.5.5. Strategic Overview
    • 13.4.6. Pfizer, Inc,
      • 13.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.6.2. Financial Overview
      • 13.4.6.3. Product Portfolio
      • 13.4.6.4. SWOT Analysis
      • 13.4.6.5. Strategic Overview
    • 13.4.7. GlaxoSmithKline plc,
      • 13.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.7.2. Financial Overview
      • 13.4.7.3. Product Portfolio
      • 13.4.7.4. SWOT Analysis
      • 13.4.7.5. Strategic Overview
    • 13.4.8. Mallinckrodt plc,
      • 13.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.8.2. Financial Overview
      • 13.4.8.3. Product Portfolio
      • 13.4.8.4. SWOT Analysis
      • 13.4.8.5. Strategic Overview
    • 13.4.9. BioCorRx, Inc.,
      • 13.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.9.2. Financial Overview
      • 13.4.9.3. Product Portfolio
      • 13.4.9.4. SWOT Analysis
      • 13.4.9.5. Strategic Overview
    • 13.4.10. Glenmark Pharmaceuticals Ltd
      • 13.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.4.10.2. Financial Overview
      • 13.4.10.3. Product Portfolio
      • 13.4.10.4. SWOT Analysis
      • 13.4.10.5. Strategic Overview
  • 13.5. Competitive Business Strategies
Back to Top
전화 문의
F A Q